Venrock Adviser, LLC

NEW YORK, NY · CIK 1615982 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2014 · limited liability company

Assets managed$4.5bn
Staff11 · 11 in investment roles
Main clients (by assets)Private funds 100%
Private funds7 (1 hedge) · $4.5bn gross assets
Form ADV · 2026-04-28SEC adviser record

Legal entityVENROCK ADVISER, LLC (US)

Kindhedge funds, private equity
Others nearbyNew York, NY, Palo Alto, CA

As an employer

Offices in1 country
Private fundshedge 1, private equity 6

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

City	Country	People
New York, NY (main office)United States	United States	about 11
Palo Alto, CAUnited States	United States

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$3.3bn reported value +23.1% vs Q1 2026

33positions

80.4%in top 10

4 new 5 added 5 reduced 4 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change	Shares change
1	APOGEE THERAPEUTICS INC COM COM		8,493,321	$1.1bn34.18%	34.18%	Unchanged
2	ORUKA THERAPEUTICS INC COM ORKA	ORKA	4,148,428	$394.8m11.97%	11.97%	Unchanged
3	ERASCA INC COM ERAS	ERAS	17,891,812	$327.8m9.94%	9.94%	Added +1.5m	+1,509,000 9.2%
4	SPYRE THERAPEUTICS INC COM NEW SYRE	SYRE	2,985,448	$265.0m8.04%	8.04%	Reduced -700.0k	-700,000 -19.0%
5	DIANTHUS THERAPEUTICS INC COM DNTH	DNTH	1,180,000	$115.0m3.49%	3.49%	Unchanged
6	OCULAR THERAPEUTIX INC COM OCUL	OCUL	10,346,926	$101.6m3.08%	3.08%	Unchanged
7	DAMORA THERAPEUTICS INC COM NEW COM NEW		3,603,595	$93.7m2.84%	2.84%	Unchanged
8	SAVARA INC COM SVRA	SVRA	14,745,943	$90.8m2.75%	2.75%	Added +1.0m	+1,005,568 7.3%
9	JADE BIOSCIENCES INC COM NEW JBIO	JBIO	3,220,364	$71.6m2.17%	2.17%	Unchanged
10	COGENT BIOSCIENCES INC COM COGT	COGT	1,642,166	$63.6m1.93%	1.93%	Reduced -357.8k	-357,834 -17.9%
11	VIRIDIAN THERAPEUTICS INC COM VRDN	VRDN	3,257,917	$59.8m1.81%	1.81%	Reduced -624.8k	-624,792 -16.1%
12	VOR BIOPHARMA INC COM NEW VOR	VOR	3,041,719	$56.0m1.70%	1.70%	Unchanged
13	DYNE THERAPEUTICS INC COM DYN	DYN	2,173,913	$48.3m1.46%	1.46%	Unchanged
14	MAZE THERAPEUTICS INC COM MAZE	MAZE	1,602,034	$47.8m1.45%	1.45%	Unchanged
15	RELMADA THERAPEUTICS INC COM RLMD	RLMD	6,844,305	$47.4m1.44%	1.44%	Added +2.0m	+2,000,925 41.3%
16	ORIC PHARMACEUTICALS INC COM ORIC	ORIC	4,319,765	$46.8m1.42%	1.42%	Unchanged
17	CRESCENT BIOPHARMA INC. COM CBIO	CBIO	2,133,576	$38.4m1.16%	1.16%	Unchanged
18	ZURA BIO LTD CLASS A ORD SHS ZURA	ZURA	6,434,990	$38.0m1.15%	1.15%	Unchanged
19	ADLAI NORTYE LTD SPONSORED ADS ANL	ANL	3,212,731	$36.9m1.12%	1.12%	Unchanged
20	ENLIVEN THERAPEUTICS INC COM ELVN	ELVN	526,331	$26.7m0.81%	0.81%	Reduced -1.2m	-1,200,000 -69.5%
21	CYBIN INC COM NEW COM NEW		3,851,654	$25.5m0.77%	0.77%	Unchanged
22	CULLINAN THERAPEUTICS INC COM CGEM	CGEM	1,379,965	$25.1m0.76%	0.76%	Unchanged
23	CENTURY THERAPEUTICS INC COM IPSC	IPSC	8,695,652	$21.3m0.65%	0.65%	Unchanged
24	ARTIVA BIOTHERAPEUTICS INC COM ARTV	ARTV	2,043,596	$19.8m0.60%	0.60%	Added +434.0k	+434,027 27.0%
25	CYTOMX THERAPEUTICS INC COM CTMX	CTMX	4,982,124	$18.7m0.57%	0.57%	Reduced -5.0m	-5,000,000 -50.1%
26	ACHIEVE LIFE SCIENCES INC COM ACHV	ACHV	2,751,032	$18.0m0.54%	0.54%	New
27	PARABILIS MEDICINES INC COM PBLS	PBLS	625,000	$17.1m0.52%	0.52%	New
28	SURROZEN INC COM NEW SRZN	SRZN	632,931	$16.4m0.50%	0.50%	Unchanged
29	KORRO BIO INC COM KRRO	KRRO	1,009,500	$13.3m0.40%	0.40%	Unchanged
30	ALTO NEUROSCIENCE INC COM SHS ANRO	ANRO	500,000	$13.2m0.40%	0.40%	Unchanged
31	X4 PHARMACEUTICALS INC COM NEW XFOR	XFOR	1,934,253	$9.0m0.27%	0.27%	Added +1.6m	+1,603,728 485.2%
32	RESEARCH ALLIANCE CORP III ORD SHS CL A RACC	RACC	300,000	$3.2m0.10%	0.10%	New
33	INMED PHARMACEUTICALS INC COM NEW INM	INM	32,685	$50.7k0.00%	0.00%	New

Sold out since Q1 2026

Security	Ticker	Shares held before	Value then
KALVISTA PHARMACEUTICALS INC KALV	KALV	6,474,485	$130.3m6.5m shares
ENGENE HOLDINGS INC		4,771,414	$32.5m4.8m shares
TENAX THERAPEUTICS INC TENX	TENX	1,675,262	$26.8m1.7m shares
SEPTERNA INC SEPN	SEPN	506,056	$12.2m506.1k shares